New offering in Specialty Care connects patients, providers, payers and the life science industry to shorten time to therapy, improve patient adherence and reduce abandonment
THE WOODLANDS, Texas (April 4, 2018) – ExpressCoverage™ is a new and powerful patient support platform that connects patients, providers, payers and the life science industry to facilitate patient access and adherence for improved outcomes. This offering is the result of a collaboration between McKesson Specialty Health, a division of McKesson Corporation that works with stakeholders across the healthcare delivery system to preserve and strengthen specialty care, and CoverMyMeds, part of McKesson Rx Technology Solutions and a leader in electronic prior authorization (ePA) solutions. Express Coverage leverages the prior authorization (PA) expertise of CoverMyMeds and the broad spectrum of high-touch biopharma-sponsored McKesson services to help physicians and patients better navigate the complexities of a specialty therapy journey. The goal of ExpressCoverage is to help patients benefit from a seamless support system that improves access to medications, supports adherence and reduces prescription abandonment, ultimately resulting in better care delivery and superior patient outcomes.
“Patients are our number one priority, and we are constantly looking for ways to improve their experience and access to medications, from the first discussion with their physician to the point of picking up the prescription, followed by ongoing education and adherence support,” said Bill Nolan, vice president and general manager, McKesson Specialty Health. “The real-time connectivity between the CoverMyMeds’ network of providers, payers and pharmacies, and McKesson’s hub support services will reduce barriers to access, help patients start therapy quickly and stay on therapy longer.”
ExpressCoverage leverages the expertise and technology of both McKesson and CoverMyMeds, offering key benefits to all industry stakeholders, including:
- Increased speed to therapy and improved PA turnaround times
- Reduced patient abandonment by preventing fallout points, leading to improved patient outcomes
- Reduced errors and administrative burden for the provider
- Increased visibility and ability for McKesson to help drive intervention planning across the patient journey, leveraging data and insights from each step in the prescription workflow
“Prior authorization, when done manually, often results in treatment delays and gaps in therapy for patients. The prior authorization process impacts approximately 300 million prescriptions each year, and of those, roughly 36 percent are abandoned,” said Erica Conroy, vice president of Operations, CoverMyMeds. “The integration of CoverMyMeds’ ePA solution with McKesson Specialty Health’s hub workflow helps reduce the administrative burden for providers while helping patients get the medication they need and improving outcomes.”
ExpressCoverage is part of McKesson Specialty Health’s comprehensive portfolio of services for biopharma and life science companies. Leveraging proprietary technology and innovative solutions along the entire lifecycle of a drug, McKesson Specialty Health helps biopharma customers and partners bring life-changing medications to market and connect the patient to their therapies.
Those attending eyeforpharma are invited to attend McKesson’s keynote presentation, Transforming Access to Therapy Through Innovations Along the Patient Journey, on April 10 at 9:05 a.m. to learn more.
About McKesson Specialty Health
McKesson Specialty Health, a division of McKesson Corporation, works together with stakeholders across the healthcare delivery system to preserve and strengthen specialty care, passionately driven by the benefits it provides patients and the system as a whole. Through innovative provider, practice management, biopharma and payer solutions, McKesson Specialty Health focuses on improving the financial, operational and business health of our customers and partners so they may provide the best care to patients. At McKesson Specialty Health, we believe that we are all in this together. For more information, visit www.McKesson.com/Pharmaceutical-Manufacturers.
About CoverMyMeds
CoverMyMeds, part of McKesson Rx Technology Solutions, is a leader in electronic prior authorization (ePA) solutions, and one of the fastest growing healthcare technology companies in the U.S. CoverMyMeds’ software suite automates the medication prior authorization process for more than 500 electronic health records (EHRs) systems, 62,000 pharmacies, 700,000 providers and most health plans and PBMs. By ensuring appropriate access to medications, the company helps its customers avoid billions of dollars each year in administrative waste and avoidable medical spending caused by prescription abandonment. For more information, visit www.covermymeds.com.